Lv41
460 积分 2024-06-19 加入
Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell (CART) Therapy in Patients with Relapse-Refractory Multiple Myeloma with Extramedullary Disease
1分钟前
求助中
Efficacy and Safety of BCMA-Specific CAR T Cell-Based Therapy in Relapsed/Refractory Multiple Myeloma Patients with Extramedullary Disease
6分钟前
求助中
Reconstitution of the Multiple Myeloma Microenvironment Following Lymphodepletion with BCMA CAR-T Therapy
1个月前
已完结
Impact of radiation therapy on the immunological tumor microenvironment
6个月前
已完结
Whole-body CT scanning radiation improves the immune microenvironment of tumor tissues to enhance the antitumor effect of ICI
6个月前
已完结
Treatment of Porokeratosis Ptychotropica With a Topical Combination of Cholesterol and Simvastatin
8个月前
已完结
Tagraxofusp in combination with pomalidomide and dexamethasone in relapsed and / or refractory multiple myeloma shows encouraging preliminary efficacy with a manageable safety profile
10个月前
已完结
Toxic epidermal necrolysis‐like cutaneous toxicity following chimeric antigen receptor T‐cell therapy in recurrent large B‐cell lymphoma
11个月前
已完结
Dermatologic Adverse Events Associated With Chimeric Antigen Receptor T-Cell Therapy: A Pharmacovigilance Analysis of the FDA Reporting System
11个月前
已完结
Cutaneous toxicity of CAR T‐cell therapy: Case report of a bullous life‐threatening reaction
1年前
已完结
皖公网安备34019202002308
